Cardio-Oncology: Learning From the Old, Applying to the New.
Cardio-Oncology: Learning From the Old, Applying to the New.
复制标题
DOI：
10.3389/fcvm.2020.601893
复制
发表时间：
2020
影响因子：
3.6
通讯作者：
Herrmann J
中科院分区：
文献类型：
--
作者：
Abe JI;Yusuf SW;Deswal A;Herrmann J
最近癌症药物批准的激增为我们的心脏肿瘤学提供了一个新的、独特的时代，这是现代医学以前从未经历过的：“传统”循证医学的可用性不断减少。肿瘤学的急剧而快速的变化使得仅仅遵循肿瘤学家的实践来建立有意义的循证心脏肿瘤学实践变得困难，有时甚至不可能。对于现代心脏肿瘤学家来说，似乎需要一种更积极主动的方法和方法。我们相信，只有通过这样的方法（学习旧的，应用新的），心脏肿瘤科医生才能获得有意义的证据来在这个新时代进行日常实践。
The recent surge in cancer drug approval has provided us in cardio-oncology with a new and unique era, which modern medicine has not experienced before: the diminishing availability of “conventional” evidence-based medicine. The drastic and quick changes in oncology has made it difficult, and at times even impossible, to establish a meaningful evidence-based cardio-oncology practice by simply following the oncologists' practice. For the modern cardio-oncologist, it seems that a more proactive approach and methodology is needed. We believe that only through such an approach (learn from the old, and apply to the new) the cardio-oncologist will obtain meaningful evidence to perform their every-day practice in this new era.